Shanghai Xuerong Bio-Technology Co. Ltd. Class A

Shanghai Xuerong Bio-Technology Co. Ltd. Class A

SSZSE:300511
3.97
CNY
-0.04
(-1.00%)
0.07EPS
69.76P/E
3.12BMarket Cap
Shanghai Xuerong Bio-Technology Co. Ltd. Class A
SZSE:300511
(Shenzhen Stock Exchange)

Recent

price

3.97

P/E

ratio

69.76

div

yld

0.76%

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
0.94
1.5
2.41
2.78
3.19
3.81
3.15
4.27
4.55
5.07
4.79
4.77
5.18
4.35
3.34
3.68
Revenue per Share
0.21
0.22
0.25
0.3
0.39
0.4
0.29
0.35
0.51
0.53
-0.72
-0.59
-0.38
-1.24
0.05
0.07
Basic EPS, GAAP
- -
- -
0.11
0.28
-0.03
-1.44
-2.01
-0.08
0.64
0.17
-0.91
0.1
-1.49
0.22
0.56
- -
Free Cash Flow per Basic Share
0.07
0.1
0.17
0.23
0.21
0.28
0.18
0.26
0.31
0.27
0.24
0.12
0.12
0.13
0.07
0.03
Dividend per Share
0.97
1.15
1.33
1.63
1.98
3
3.19
3.61
4.05
4.57
3.78
3.47
3.12
1.88
2.52
2.46
Book Value per Share
0.7
0.58
0.74
1.05
1.38
2.53
2.67
3
3.44
3.99
3.03
3.02
2.5
1.28
2.05
2.01
Tangible Book Value per Share
323
322
320
320
320
262
422
433
432
435
433
487
495
498
596
641
Basic Weighted Avg Shares
302
483
773
888
1,019
999
1,330
1,847
1,965
2,202
2,073
2,320
2,565
2,162
1,988
2,361
Sales/Revenue/Turnover
21.67
16.49
14.97
15.65
16.86
13.65
12.27
6.95
14.51
13.9
-3.23
4.33
-1.63
-4.62
4.98
9.59
Operating Margin (%)
- -
- -
105
114
132
122
194
258
284
322
314
341
325
374
338
- -
Depreciation Expense
67
72
79
95
123
105
122
151
220
230
-312
-287
-188
-617
30
45
Net Income, GAAP
- -
- -
7.71
4.58
2.73
1.28
- -
12.07
- -
- -
- -
- -
- -
- -
1.98
0.53
Effective Tax Rate (%)
22.11
14.96
10.18
10.74
12.1
10.49
9.2
8.2
11.22
10.46
-15.03
-12.38
-7.33
-28.54
1.5
1.9
Profit Margin (%)
-151
-366
-486
-446
-585
-528
-991
-588
-586
-159
-732
-105
-1,346
-1,402
-1,151
-1,066
Working Capital
143
415
289
275
187
108
766
776
682
1,059
961
997
973
982
241
228
LT Debt
350
381
433
529
643
1,290
1,416
1,569
1,740
2,008
1,652
1,626
1,432
823
1,513
1,476
Total Equity
- -
- -
5.43
6.27
7.77
5.27
- -
3.86
- -
- -
- -
- -
- -
- -
1.46
1.77
Return on Invested Capital (%)
- -
- -
10.26
11.45
12.48
8.22
- -
7.89
- -
- -
- -
- -
- -
- -
2.83
3.22
Return on Capital (%)
- -
21.28
19.74
20.09
21.31
10.93
9.17
10.25
13.32
12.26
-16.9
-16.83
-11.41
-49.5
2.34
3.13
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
531
1,020
997
LT Borrowings
740
216
212
LT Finance Leases
17
16
16
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
641
641
641
Market Capitalization
4,441
3,223
3,121

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
774
607
588
Cash, Cash Equivalents & STI
298
176
128
Accounts Receivable, Net
46
42
44
Inventories
400
355
380
Total Current Liabilities
1,177
1,633
1,653
Payables & Accruals
- -
- -
- -
ST Debt
531
1,020
997
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
15.76%
2.02%
83.83%
Free Cash Flow
43.9%
-462.48%
206.4%
Net Income, GAAP
-7.87%
-30.86%
-104.83%
Sales/Revenue/Turnover
8.13%
-1.43%
-8.09%
Total Cash Common Dividend
-0.93%
-15.34%
-36.31%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
604
467
570
521
2,162
2025
441
350
- -
663
1,988
2026
679
477
542
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
-0.3
-0.04
-0.91
-1.24
2025
0.01
-0.18
- -
0.14
0.05
2026
0.27
-0.24
-0.1
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.05
0.03
0.03
0.13
2025
0.02
0.04
- -
-0.01
0.07
2026
0.01
0.01
0.01
- -
- -
Business
Shanghai Xuerong Bio-Technology Co., Ltd. is a China-based agricultural biotechnology company primarily engaged in the industrialized research, development, factory cultivation, processing, and distribution of fresh edible fungi. Founded in 1997 and headquartered in Shanghai, China, the company operates across the modern bio-agriculture sector, utilizing controlled-environment agriculture and automated factory-farming systems. Its core product portfolio is marketed primarily under the Xuerong brand and comprises fresh edible mushrooms, including enoki mushrooms; white beech mushrooms and brown beech mushrooms; king oyster mushrooms; seafood mushrooms; shiitake mushrooms; and cordyceps militaris; as well as value-added deep-processed mushroom foods; fungal extract dietary supplements; functional nutritional formulations; and bio-organic fertilizers derived from recycled substrate waste. Shanghai Xuerong Bio-Technology operates an integrated nationwide network of industrialized production bases across key agricultural regions in Shanghai, Jilin, Heilongjiang, Sichuan, Guizhou, Shandong, Gansu, and Guangdong, supplying domestic wholesale markets, modern retail supermarket chains, food service operators, and e-commerce channels, while exporting to international markets in Southeast Asia, North America, and Europe. In recent operational and strategic developments, the company has accelerated the digital transformation of its factory-farming facilities through intelligent climate automation and energy-efficient cultivation technologies; broadened its product line into health-oriented functional fungal ingredients and convenient mushroom-based food products; entered into strategic research partnerships with agricultural research institutes to advance strain breeding and germplasm optimization; and restructured regional production capacities while enhancing cold-chain logistics integrations to strengthen operational resilience and market leadership in the industrial mushroom farming sector.